ESC Premium Access

Effect of Ivabradine on Mortality in Patients with heart failure and a reduced left ventricular ejection fraction not receiving a beta-blocker: an analysis from SHIFT.

Congress Presentation

About the speaker

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
82 presentations

9 more presentations in this session

Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET

Speaker: Doctor Y. Mareev (Haifa, IL)


The glucagon-like peptide 1 agonist liraglutide increases heart rate in heart failure patients

Speaker: Doctor R. Tougaard (Aarhus, DK)


Effect of sacubitril/valsartan on plasma biomarkers that reflect extracellular matrix regulatory mechanisms and collagen synthesis in patients with heart failure and reduced ejection fraction.

Speaker: Doctor M. Zile (Charleston, US)


Long-term outcome in myocardial infarction patients with heart failure treated with aldosterone receptor antagonist in relation to ejection fraction and kidney function

Speaker: Doctor I. Lofman (Stockholm, SE)


Effect of patiromer on serum K+ in hyperkalaemic patients with HF: Pooled results from the AMETHYST-DN, OPAL-HK and TOURMALINE trials

Speaker: Doctor I. Pina (Philadelphia, US)


Access the full session

Can we teach heart failure drugs new tricks?

Speakers: Professor J. Cleland, Doctor Y. Mareev, Doctor R. Tougaard, Doctor M. Zile, Doctor I. Lofman...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb